BioSpace News Archive

Cocrystal Pharma, Inc., a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced that Dr. Gary Wilcox and Dr. Sam Lee, have been selected to present at the World Antiviral Conference on Thursday, November 12, 2020 at 1:20 PM EST.

Applied Molecular Transport (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the unique mechanism of action of AMT-101 and preclinical data supporting its potential as a treatment for ulcerative colitis (UC), and other inflammatory diseases, have been published in The Journal of Immunology.

Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the presentation of preclinical data on its lead immunotherapy candidate NL-201, an IL-2 and IL-15 agonist, at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, is pleased to announce the results of its 2020 Annual Meeting of Shareholders that was held virtually today, being Monday, November 9, 2020

Dynamics Inc., a global leader in edge-to-edge flexible electronics and high-intensity UV technology, today announced a major breakthrough in the fight against SARS-CoV-2, the virus that causes COVID-19.

Thermo Fisher Scientific today unveiled the Thermo Scientific Axia ChemiSEM, a cost-effective, floor-model scanning electron microscope (SEM) that takes materials micro-structural analysis and defect discovery to a new level of speed and simplicity.

Glympse Bio (Glympse), a biotechnology company advancing the way diseases are understood, tracked, and treated, today announced that it will present clinical safety data from its First in Human healthy volunteer study, and data from a gene expression study of patients with advanced fibrosis at the American Association for the Study of Liver Disease (AASLD) 2020 Annual Meeting

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for the third quarter ended September 30, 2020 and provided a corporate update.

Market Uptake Growing with Manufacturers Ranging from Big Pharma and Mid-Tier to Emerging

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today announced that Mike Raab , president and chief executive officer of Ardelyx, will participate in a fireside chat at the Jefferies Virtu